PortfoliosLab logoPortfoliosLab logo
ANIK vs. PRG
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ANIK vs. PRG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Anika Therapeutics, Inc. (ANIK) and PROG Holdings, Inc. (PRG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ANIK achieves a 100.62% return, which is significantly higher than PRG's 50.60% return. Over the past 10 years, ANIK has underperformed PRG with an annualized return of -8.91%, while PRG has yielded a comparatively higher 8.74% annualized return.


ANIK

1D
6.70%
1M
25.52%
6M
108.88%
YTD
100.62%
1Y
123.15%
3Y*
-5.75%
5Y*
-13.64%
10Y*
-8.91%
ALL TIME*
5.27%

PRG

1D
2.47%
1M
-0.25%
6M
36.90%
YTD
50.60%
1Y
46.90%
3Y*
4.74%
5Y*
0.90%
10Y*
8.74%
ALL TIME*
7.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.26M$1.18M$1.16M
$25.64M$22.44M$21.41M

ANIK vs. PRG - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ANIK
Anika Therapeutics, Inc.
100.62%-41.62%-27.36%-23.45%-17.39%-20.84%-12.71%54.27%-37.66%10.11%
PRG
PROG Holdings, Inc.
50.60%-28.95%38.41%83.01%-62.56%-16.26%11.71%36.15%5.81%24.96%

Correlation

The correlation between ANIK and PRG is 0.19, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.19

Correlation (3Y)
Balances recent behavior with more history.

0.29

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.29

Correlation (10Y)
Provides a long-term view across more market conditions.

0.31

Correlation (All Time)
Calculated using the full available price history since May 4, 1993

0.14

The correlation between ANIK and PRG shifts across timeframes, from 0.14 (all time) to 0.31 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ANIK:

$258.02M

PRG:

$1.76B

EPS

ANIK:

-$0.27

PRG:

$3.61

PS Ratio

ANIK:

2.24

PRG:

0.72

PB Ratio

ANIK:

1.89

PRG:

2.23

Total Revenue (TTM)

ANIK:

$120.65M

PRG:

$2.48B

Gross Profit (TTM)

ANIK:

$75.00M

PRG:

$893.15M

EBITDA (TTM)

ANIK:

$2.72M

PRG:

$981.94M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Anika Therapeutics, Inc.

PROG Holdings, Inc.

Return for Risk

ANIK vs. PRG — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ANIK
ANIK Risk / Return Rank: 9696
Overall Rank
ANIK Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
ANIK Sortino Ratio Rank: 9595
Sortino Ratio Rank
ANIK Omega Ratio Rank: 9595
Omega Ratio Rank
ANIK Calmar Ratio Rank: 9696
Calmar Ratio Rank
ANIK Martin Ratio Rank: 9898
Martin Ratio Rank

PRG
PRG Risk / Return Rank: 7272
Overall Rank
PRG Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
PRG Sortino Ratio Rank: 7676
Sortino Ratio Rank
PRG Omega Ratio Rank: 7171
Omega Ratio Rank
PRG Calmar Ratio Rank: 7171
Calmar Ratio Rank
PRG Martin Ratio Rank: 6969
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ANIK vs. PRG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Anika Therapeutics, Inc. (ANIK) and PROG Holdings, Inc. (PRG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ANIKPRGDifference
Sharpe ratioReturn per unit of total volatility

+1.77

Sortino ratioReturn per unit of downside risk

+1.67

Omega ratioGain probability vs. loss probability

1.48

1.20

+0.28

Calmar ratioReturn relative to maximum drawdown

5.95

1.31

+4.64

Martin ratioReturn relative to average drawdown

22.34

2.66

+19.68

ANIK vs. PRG - Sharpe Ratio Comparison

The current ANIK Sharpe Ratio is 2.66, which is higher than the PRG Sharpe Ratio of 0.89. The chart below compares the historical Sharpe Ratios of ANIK and PRG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ANIK vs. PRG - Drawdown Comparison

The maximum ANIK drawdown since its inception was -95.88%, which is greater than PRG's maximum drawdown of -80.87%. Use the drawdown chart below to compare losses from any high point for ANIK and PRG.


Loading charts...

Drawdown Indicators


ANIKPRGDifference

Max Drawdown

Largest peak-to-trough decline

-95.88%

-80.87%

-15.01%

Max Drawdown (1Y)

Largest decline over 1 year

-22.56%

-31.21%

+8.65%

Max Drawdown (3Y)

Largest decline over 3 years

-71.83%

-51.86%

-19.97%

Max Drawdown (5Y)

Largest decline over 5 years

-82.01%

-73.96%

-8.05%

Max Drawdown (10Y)

Largest decline over 10 years

-88.96%

-80.87%

-8.09%

Current Drawdown

Current decline from peak

-73.72%

-30.58%

-43.14%

Average Drawdown

Average peak-to-trough decline

-48.52%

-28.44%

-20.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.00%

15.34%

-9.34%

Volatility

ANIK vs. PRG - Volatility Comparison

Anika Therapeutics, Inc. (ANIK) has a higher volatility of 16.49% compared to PROG Holdings, Inc. (PRG) at 10.69%. This indicates that ANIK's price experiences larger fluctuations and is considered to be riskier than PRG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ANIKPRGDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.49%

10.69%

+5.80%

Volatility (6M)

Calculated over the trailing 6-month period

42.88%

38.70%

+4.18%

Volatility (1Y)

Calculated over the trailing 1-year period

50.45%

45.91%

+4.54%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

45.11%

50.93%

-5.82%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

47.69%

49.90%

-2.21%

Dividends

ANIK vs. PRG - Dividend Comparison

ANIK has not paid dividends to shareholders, while PRG's dividend yield for the trailing twelve months is around 1.23%.


PositionTTM20252024202320222021202020192018201720162015
ANIK
Anika Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PRG
PROG Holdings, Inc.
1.23%1.76%1.14%0.00%0.00%0.00%0.26%0.25%0.30%0.28%0.32%0.42%

Financials

ANIK vs. PRG - Financials Comparison

This section allows you to compare key financial metrics between Anika Therapeutics, Inc. and PROG Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

ANIK vs. PRG - Profitability Comparison

The chart below illustrates the profitability comparison between Anika Therapeutics, Inc. and PROG Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

ANIK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Anika Therapeutics, Inc. reported a gross profit of 21.24M and revenue of 32.61M. Therefore, the gross margin over that period was 65.2%.

PRG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, PROG Holdings, Inc. reported a gross profit of 217.34M and revenue of 564.80M. Therefore, the gross margin over that period was 38.5%.

ANIK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Anika Therapeutics, Inc. reported an operating income of 2.95M and revenue of 32.61M, resulting in an operating margin of 9.1%.

PRG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, PROG Holdings, Inc. reported an operating income of 73.93M and revenue of 564.80M, resulting in an operating margin of 13.1%.

ANIK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Anika Therapeutics, Inc. reported a net income of 3.31M and revenue of 32.61M, resulting in a net margin of 10.2%.

PRG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, PROG Holdings, Inc. reported a net income of 37.03M and revenue of 564.80M, resulting in a net margin of 6.6%.


Frequently Asked Questions


ANIK and PRG have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ANIK has higher volatility (16.49%) compared to PRG (10.69%). In terms of maximum drawdown, ANIK dropped -95.88% vs PRG's -80.87%.

ANIK currently has the higher Sharpe Ratio (2.66 vs 0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ANIK and PRG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer